We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Alkermes PLC | NASDAQ:ALKS | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.53 | -2.16% | 24.01 | 23.58 | 24.54 | 24.28 | 23.26 | 23.85 | 2,843,963 | 00:55:10 |
From May 2019 to May 2024
Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Cowen and Company 37th Annual Health Care Conference on Tuesday, Mar. 7, 2017 at 8:00 a.m. ET (1:00 p.m. GMT) from The Boston Marriott Copley Place in Boston. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170228006477/en/
Alkermes plcJennifer Zibuda, +1 781-609-6129Corporate Communications
1 Year Alkermes Chart |
1 Month Alkermes Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
